The (C 5 H 5 - n Me n ) 2 Zr[η 2 -C 2 (SiMe 3 ) 2 ] ( n = 2−5; 1,3-dimethyl, 1,2,3-trimethyl) ( 2C − F ) complexes were prepared by the reduction of corresponding zirconocene dichlorides with magnesium in THF in the presence of bis(trimethylsilyl)acetylene (BTMSA). All of them are stable in the absence of THF. Crystal structures of (C 5 HMe 4 ) 2 Zr[η 2 -C 2 (SiMe 3 ) 2 ] ( 2E ) and (C 5 Me 5 ) 2 Zr[η 2 -C 2 (SiMe 3 ) 2 ] ( 2F ) and of the analogous titanium complexes are isomorphous. The red shift of the ν(C⋮C) vibration and the downfield shift of 13 C δ(C⋮C) indicate that BTMSA in 2C − F is more strongly coordinated than in analogous titanocene complexes. The nonisolated complex (C 5 H 4 Me) 2 Zr[η 2 -C 2 (SiMe 3 ) 2 ](THF) ( 2 B ·THF) rearranges after the loss of THF to give the dimer [(η 5 -C 5 H 4 Me)(η 1 -C(SiMe 3 ) CH(SiMe 3 )Zr(μ-η 1:η 5 -C 5 H 3 Me)] 2 ( 3B ).
No takes yet. Share an insight, caveat, or question.
Hiller et al. (1996) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: